Trial Profile
Prospective, randomized trial of rapamycin [sirolimus] plus estradiol-eluting stents versus rapamycin-eluting stents for the reduction of coronary restenosis (ISAR-PEACE)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Estradiol
- Indications Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
- Focus Therapeutic Use
- Acronyms ISAR-PEACE
- 27 Feb 2007 New trial record.